The Munich Score: A Clinical Index to Predict Survival in Ambulatory Patients With Chronic Heart Failure in the Era of New Medical Therapies

The incorporation of changes over time in hemodynamic parameters allowed for an improved baseline risk stratification model for the HTx selection process, especially in the era of new medical therapies such as β-blocker therapy. All significant variables of the Munich score can be obtained in routinely performed non-invasive tests.